Unbiased financial chart thread!, page-6

The little bit you left out is very important!

"The corresponding receipts and expenses data that generate that Ratio are displayed in the graphic below together with their regression fit trendlines. Operating Expenses show trend compound growth of 21.4% per quarter. Cash Receipts display trend compound growth of 51.4% per quarter."


This is from the half yearly report and we will be updated again on receipts in the 4C in approximately 6 weeks, any trend of receipts and revenue that stays anywhere near the last half would be absolutely amazing.

From the half report!

Alexium continues to see forward momentum in both revenue and gross profit from increased order volume with existing customers and new customers coming on line. Chemistry sales grew over 1000% to $11,193,372 for the period, an increase from $973,121 from the previous half year report, from core product sales. The group’s net loss for the period, $5,806,993, down from $9,008,753 for the half-year ended 31 December 2015, is related to increased sales revenue and improved margins on customer orders.

Infrastructure, supply chain systems and purchasing strategy implemented during 2016 continue to drive gross profit sharply upward. Alexium’s top-line growth from 2015 to 2016 (from $1.0M to $13.3M AUD) was largely due to the success of winning new business not only due to the performance of Alexium’s chemistries, but by offering those chemistries at competitive price points to much larger competitors. As the scale of Alexium’s sales have increased, the company is now able to buy raw materials in bulk, a larger global footprint has dramatically reduced the shipping component of our COGS and air freight during scale-up is being replaced by far less expensive conventional ocean freight. The effect of these strategic efforts has resulted in a 14 percentage point increase in gross profit from the first half to the second half of 2016 and gross profit on new specialty chemistry sales since the beginning of 2017 have exceeded 30%. Over the course of 2017, as more product lines achieve the same economies of scale, Alexium is forecasting average gross prots across all product lines to exceed 40%.

Commenting on the reporting period, Alexium Deputy CEO Dirk Van Hyning stated: “The second half of 2016 realized the fruition of a lot of strategic directives implemented over several years. As Alexium continues to expand our sales in FR and further expand our product offering into adjacent markets such as cooling chemistry and beyond, we now have the infrastructure to compete on pricing with anyone and realize healthy margins for our shareholders.”


It should be a great few months ahead with even further excellent revenue growth being achieved!

Cheers.